|
||||||
|
 | Fusion Gene Summary |
| Fusion Gene ORF analysis |
| Fusion Genomic Features |
| Fusion Protein Features |
| Fusion Gene Sequence |
| Fusion Gene PPI analysis |
| Related Drugs |
| Related Diseases |
Fusion gene:ACAP2-KPNA4 (FusionGDB2 ID:1220) |
Fusion Gene Summary for ACAP2-KPNA4 |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: ACAP2-KPNA4 | Fusion gene ID: 1220 | Hgene | Tgene | Gene symbol | ACAP2 | KPNA4 | Gene ID | 23527 | 3840 |
| Gene name | ArfGAP with coiled-coil, ankyrin repeat and PH domains 2 | karyopherin subunit alpha 4 | |
| Synonyms | CENTB2|CNT-B2 | IPOA3|QIP1|SRP3 | |
| Cytomap | 3q29 | 3q25.33 | |
| Type of gene | protein-coding | protein-coding | |
| Description | arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 2Arf GAP with coiled coil, ANK repeat and PH domains 2centaurin-beta-2 | importin subunit alpha-3importin alpha Q1importin subunit alpha-4karyopherin alpha 4 (importin alpha 3) | |
| Modification date | 20200313 | 20200327 | |
| UniProtAcc | Q15057 | O00629 | |
| Ensembl transtripts involved in fusion gene | ENST00000326793, ENST00000472860, | ENST00000469804, ENST00000334256, | |
| Fusion gene scores | * DoF score | 16 X 14 X 11=2464 | 5 X 4 X 4=80 |
| # samples | 22 | 5 | |
| ** MAII score | log2(22/2464*10)=-3.48542682717024 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(5/80*10)=-0.678071905112638 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
| Context | PubMed: ACAP2 [Title/Abstract] AND KPNA4 [Title/Abstract] AND fusion [Title/Abstract] | ||
| Most frequent breakpoint | ACAP2(195112819)-KPNA4(160254628), # samples:1 | ||
| Anticipated loss of major functional domain due to fusion event. | |||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Hgene | ACAP2 | GO:0030029 | actin filament-based process | 11062263 |
| Fusion gene breakpoints across ACAP2 (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
 |
| Fusion gene breakpoints across KPNA4 (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
 |
| Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| ChimerDB4 | Non-Cancer | ERR315342 | ACAP2 | chr3 | 195112819 | - | KPNA4 | chr3 | 160254628 | - |
Top |
Fusion Gene ORF analysis for ACAP2-KPNA4 |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| 5CDS-intron | ENST00000326793 | ENST00000469804 | ACAP2 | chr3 | 195112819 | - | KPNA4 | chr3 | 160254628 | - |
| In-frame | ENST00000326793 | ENST00000334256 | ACAP2 | chr3 | 195112819 | - | KPNA4 | chr3 | 160254628 | - |
| intron-3CDS | ENST00000472860 | ENST00000334256 | ACAP2 | chr3 | 195112819 | - | KPNA4 | chr3 | 160254628 | - |
| intron-intron | ENST00000472860 | ENST00000469804 | ACAP2 | chr3 | 195112819 | - | KPNA4 | chr3 | 160254628 | - |
| ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
| ENST00000326793 | ACAP2 | chr3 | 195112819 | - | ENST00000334256 | KPNA4 | chr3 | 160254628 | - | 8948 | 342 | 213 | 1838 | 541 |
| DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
| ENST00000326793 | ENST00000334256 | ACAP2 | chr3 | 195112819 | - | KPNA4 | chr3 | 160254628 | - | 0.00014464 | 0.9998553 |
Top |
Fusion Genomic Features for ACAP2-KPNA4 |
| FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
| Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
| Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page. |
 |
| Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page. |
Top |
Fusion Protein Features for ACAP2-KPNA4 |
| Four levels of functional features of fusion genes Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr3:195112819/chr3:160254628) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| ACAP2 | KPNA4 |
| FUNCTION: GTPase-activating protein (GAP) for ADP ribosylation factor 6 (ARF6). {ECO:0000269|PubMed:11062263}. | FUNCTION: Functions in nuclear protein import as an adapter protein for nuclear receptor KPNB1. Binds specifically and directly to substrates containing either a simple or bipartite NLS motif. Docking of the importin/substrate complex to the nuclear pore complex (NPC) is mediated by KPNB1 through binding to nucleoporin FxFG repeats and the complex is subsequently translocated through the pore by an energy requiring, Ran-dependent mechanism. At the nucleoplasmic side of the NPC, Ran binds to importin-beta and the three components separate and importin-alpha and -beta are re-exported from the nucleus to the cytoplasm where GTP hydrolysis releases Ran from importin. The directionality of nuclear import is thought to be conferred by an asymmetric distribution of the GTP- and GDP-bound forms of Ran between the cytoplasm and nucleus. In vitro, mediates the nuclear import of human cytomegalovirus UL84 by recognizing a non-classical NLS. In vitro, mediates the nuclear import of human cytomegalovirus UL84 by recognizing a non-classical NLS. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| Tgene | KPNA4 | chr3:195112819 | chr3:160254628 | ENST00000334256 | 0 | 17 | 233_236 | 23 | 522.0 | Compositional bias | Note=Poly-Pro | |
| Tgene | KPNA4 | chr3:195112819 | chr3:160254628 | ENST00000334256 | 0 | 17 | 43_52 | 23 | 522.0 | Motif | Nuclear localization signal | |
| Tgene | KPNA4 | chr3:195112819 | chr3:160254628 | ENST00000334256 | 0 | 17 | 137_229 | 23 | 522.0 | Region | NLS binding site (major) | |
| Tgene | KPNA4 | chr3:195112819 | chr3:160254628 | ENST00000334256 | 0 | 17 | 306_394 | 23 | 522.0 | Region | NLS binding site (minor) | |
| Tgene | KPNA4 | chr3:195112819 | chr3:160254628 | ENST00000334256 | 0 | 17 | 107_149 | 23 | 522.0 | Repeat | Note=ARM 2 | |
| Tgene | KPNA4 | chr3:195112819 | chr3:160254628 | ENST00000334256 | 0 | 17 | 150_194 | 23 | 522.0 | Repeat | Note=ARM 3 | |
| Tgene | KPNA4 | chr3:195112819 | chr3:160254628 | ENST00000334256 | 0 | 17 | 195_233 | 23 | 522.0 | Repeat | Note=ARM 4 | |
| Tgene | KPNA4 | chr3:195112819 | chr3:160254628 | ENST00000334256 | 0 | 17 | 234_278 | 23 | 522.0 | Repeat | Note=ARM 5 | |
| Tgene | KPNA4 | chr3:195112819 | chr3:160254628 | ENST00000334256 | 0 | 17 | 279_318 | 23 | 522.0 | Repeat | Note=ARM 6 | |
| Tgene | KPNA4 | chr3:195112819 | chr3:160254628 | ENST00000334256 | 0 | 17 | 319_360 | 23 | 522.0 | Repeat | Note=ARM 7 | |
| Tgene | KPNA4 | chr3:195112819 | chr3:160254628 | ENST00000334256 | 0 | 17 | 361_400 | 23 | 522.0 | Repeat | Note=ARM 8 | |
| Tgene | KPNA4 | chr3:195112819 | chr3:160254628 | ENST00000334256 | 0 | 17 | 401_443 | 23 | 522.0 | Repeat | Note=ARM 9 | |
| Tgene | KPNA4 | chr3:195112819 | chr3:160254628 | ENST00000334256 | 0 | 17 | 447_485 | 23 | 522.0 | Repeat | Note=ARM 10%3B atypical | |
| Tgene | KPNA4 | chr3:195112819 | chr3:160254628 | ENST00000334256 | 0 | 17 | 66_106 | 23 | 522.0 | Repeat | Note=ARM 1%3B truncated |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| Hgene | ACAP2 | chr3:195112819 | chr3:160254628 | ENST00000326793 | - | 2 | 23 | 1_226 | 37 | 779.0 | Domain | Note=BAR |
| Hgene | ACAP2 | chr3:195112819 | chr3:160254628 | ENST00000326793 | - | 2 | 23 | 266_361 | 37 | 779.0 | Domain | PH |
| Hgene | ACAP2 | chr3:195112819 | chr3:160254628 | ENST00000326793 | - | 2 | 23 | 399_520 | 37 | 779.0 | Domain | Arf-GAP |
| Hgene | ACAP2 | chr3:195112819 | chr3:160254628 | ENST00000326793 | - | 2 | 23 | 640_669 | 37 | 779.0 | Repeat | Note=ANK 1 |
| Hgene | ACAP2 | chr3:195112819 | chr3:160254628 | ENST00000326793 | - | 2 | 23 | 673_702 | 37 | 779.0 | Repeat | Note=ANK 2 |
| Hgene | ACAP2 | chr3:195112819 | chr3:160254628 | ENST00000326793 | - | 2 | 23 | 706_735 | 37 | 779.0 | Repeat | Note=ANK 3 |
| Hgene | ACAP2 | chr3:195112819 | chr3:160254628 | ENST00000326793 | - | 2 | 23 | 414_437 | 37 | 779.0 | Zinc finger | C4-type |
| Tgene | KPNA4 | chr3:195112819 | chr3:160254628 | ENST00000334256 | 0 | 17 | 2_58 | 23 | 522.0 | Domain | IBB |
Top |
Fusion Gene Sequence for ACAP2-KPNA4 |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
| >1220_1220_1_ACAP2-KPNA4_ACAP2_chr3_195112819_ENST00000326793_KPNA4_chr3_160254628_ENST00000334256_length(transcript)=8948nt_BP=342nt CGTTTCCCTGCGGCCAGCGCTCTACTTGGGGCGGGAGGAAGAGGGGCGGGACTGGGGCCTGACTAGTCGTCGCCGTCTTCGCGGCTGCTA TGACCAGCGGGCGAGGCGCCCTTCGCAGCTCCGCGCAACGCTAGTCGCGGCCGTGCGCCCGCCGTAGCCGTCTGCGTCCCAGCGCGGCCG CTCCCGCGGCCCCCTCGGCTTTGCCAGCGCCGCCTGCGAGGCGGAGGCAGGATGAAGATGACTGTGGATTTCGAGGAGTGTCTGAAGGAC TCGCCCCGCTTCAGGGCAGCTTTGGAAGAAGTAGAAGGTGATGTGGCAGAATTGGAACTAAAACTTGATAAGACTATGAGAAGACAACGA AATGAAGTTGTAGTTGAATTAAGGAAGAATAAAAGAGATGAACATCTCTTAAAGAGAAGGAATGTACCACATGAAGATATCTGTGAAGAC TCTGATATAGATGGTGATTATAGAGTGCAAAATACCTCTCTAGAAGCTATTGTTCAAAATGCTTCAAGTGATAACCAAGGAATTCAATTA AGTGCAGTTCAAGCTGCTAGGAAGCTTTTGTCCAGTGATCGAAATCCACCAATTGATGACTTAATAAAATCTGGAATATTGCCCATTTTA GTCCATTGTCTTGAAAGAGATGACAATCCTTCTTTACAGTTTGAAGCTGCATGGGCTTTGACAAACATTGCATCTGGAACTTCTGAACAA ACTCAAGCAGTAGTTCAGTCCAATGCTGTGCCACTTTTCCTGAGGCTTCTCCATTCACCCCATCAGAATGTCTGTGAGCAAGCAGTGTGG GCATTGGGAAATATCATAGGTGATGGGCCCCAGTGTAGAGATTATGTCATAAGTCTTGGAGTTGTGAAACCTTTACTTTCCTTCATAAGT CCATCTATTCCTATAACATTCTTAAGAAATGTTACTTGGGTTATGGTCAACTTATGTCGCCACAAAGACCCACCACCACCAATGGAAACC ATTCAGGAGATTCTTCCAGCCCTTTGTGTTTTAATTCATCACACAGATGTAAATATACTGGTAGACACAGTCTGGGCCCTCTCTTACCTT ACTGATGCTGGCAATGAACAAATACAGATGGTAATAGACTCTGGAATAGTTCCTCATTTGGTTCCTCTGCTCAGCCACCAGGAAGTTAAA GTTCAGACTGCTGCACTTAGAGCTGTGGGCAACATTGTTACTGGAACTGATGAGCAAACACAAGTAGTTTTGAACTGTGATGCTCTTTCA CACTTCCCAGCACTCCTGACACATCCCAAAGAGAAAATTAATAAAGAAGCAGTGTGGTTCCTCTCCAACATCACTGCAGGAAATCAGCAG CAGGTACAGGCAGTAATTGATGCCAATCTTGTACCAATGATAATACACCTTTTGGATAAGGGGGATTTTGGCACTCAAAAAGAAGCTGCT TGGGCCATAAGTAACTTAACAATTAGTGGAAGGAAAGATCAAGTGGCTTACCTTATCCAACAAAATGTTATCCCACCTTTTTGCAACTTG CTGACTGTAAAAGATGCACAAGTTGTGCAAGTAGTACTCGATGGACTAAGTAATATATTAAAAATGGCTGAAGATGAGGCAGAAACCATA GGCAATCTTATAGAAGAATGTGGAGGGCTGGAGAAAATTGAACAACTTCAAAATCATGAAAATGAAGACATCTACAAATTGGCCTATGAG ATCATTGATCAGTTCTTCTCTTCAGATGATATTGATGAAGACCCTAGCCTTGTTCCAGAGGCAATTCAAGGCGGAACATTTGGTTTCAAT TCATCTGCCAATGTACCAACAGAAGGGTTCCAGTTTTAGAAAGATGTTGTGGAAGTTAGGTACAATGCAGCACTGAGATATATATATATA TATGTGTGTGTGTATATATATATATATATACATATATATAAAAAGGTTTGATCCATCAAGCTTGGCTCATGGGATCTGCTGCTGCATTAA ATCGGGAAAGAAAATGTGAAGATTTCATTTGGAATCACAGAAAATGCCCAAATGAGGTCAAGATGGCGAGTGGGTGCGAGTGAGAATGAG TGGCAAAATGTAATGAAAACTTTACATGAATGCTTATTTAGGTTGTTCAAAGTAAAAAGGGCTACAGGTCACAGATCGTCAGTGCCTGAG AAAGAACATTGACTTACTCTATATCAATTGAGGGGAAAGTGCAGTACCGTCATCTTCAAGCCTTGTAAGCATAAAAGAGAATAGGCTGCC CATATAAGTCAAAGGAAAATGAGCCCAGGCCTTGCTATGAAGCAGTGTGTGAATGGACAATGTTGAATGAATGTCTGGCTCAGTGATGGA GAGCCAGGTTCATCTTTGAAATCTAGGGCTCTTCACTCATGAAGCAGACTCCTAGTCCTGGAGTGACTGTGTACGAGAGCGTGGTTGTGG TGCTGTATGTGAACGCATGCAAGCTTGATTCACCTTCAGGGGGCTGATAACCTAGTAAATCATCAAAATGAGATCATAAGTGTTAATGTA CACTGGACATGAAAACAAAGACTGGTTTAGCAGCAGACATTGGTTTACTCTGCAGCCTGTGTTTTCTGTTTCCCCCTTTCCCACCTCCTT CCCCCCACCCAATCCTTTTTTTTTTCTTTTTTGCTTTTCTTTTCTTTTTTTTTAGTTTTTATTTACTTTACCTAGTATGCCTTTTTTTAG TTGCTTCTCAAGTCAGAAAACTTTTCAGGAAGGTTTCCCTGTGCATTTGCACCAGATGAATGTTTGATGCTATGAAAAGCTTTCCATATC ATCAAAACTAATTTGTGTAGATTTTTGCATGAAAAAAATCATAAATTTCCCTCAAAATAGACTGTGTTGCAGTACACAAGTTGCCATAAT AGTATAAAACAGTAAAATGTGCTTAAAAGGCCATCCTTTTCATTTTCAGAGATAACATAAAGATCTTTGCATGAGGTAAATCTACAGCAT AGTTCATTTTTAGATTTTGTTGAGTCCTGTAAAGAAGAAGAAGAAAAAAGTTTCAGTTGTGGTAGAATACCGTGCTGTGTTTAAATGTTA CTTGTTTTCAAACTTTGTTTTCTATGAAAATGATATGGAAACTTCTAAAATGGAATTTGGTGCATATGTACTGCTGAATAAAGACCGATG AAGAGGTTTGAGTAGATGTACAAATCAAGTAATGGTTTGAACACCTTTAATAATATGCCTAATCTGTTCAATTGTTTTAGAATCTTTTTA TCTTAGATGTAGGCAGCCATGAACAATCTATTTTGAGCCACTTTAGGGAGAAAACTTTGTATTTTTAAAACTTGCATAAAAGTTATGCAA GTGGTTTTTATAAATTGGAATAATACCTCAGTTTTGAGGTTATGCACACTAAATTAAATGTGACATAAATTAATTTGTACAAAAAGAACT CTTTATAAGGTGGCTCATTGTAGGAAATCCTGTGCCTTCCCCTTTGAGCACAAGTGTTGCATGAACAACAGTTTGCTATAAGAAACATAC CAGATTAGCCACCATTAGCATCTATATCTACTTTGTGTTTAAAAATCAACTGGTAATTCTGAAACACTGTAGAATGGATAAAAATTATTT TGTGATCATAACTCTTTGTTGAACTAGAGTATTTTTGCAGCATTCCTTGTCATCAGAAACATGGTTAAAGTTTAAAACTAGAAGCAGCAG AAAACTAGCTTGTAAAATTTATCCAAGTAGAGTGCAGGCTAGGCTGTCTTGGGGAAATAAACATTAAAACTTAAAGCAATGTTTTACATG GGGTGTGTGTGTGTGGTGTGTGGATTTTTTTTTTTTTATAAAGTTAGAGTATAATTCAATGGCTTACATTAGCTTCCTGTCTTTTTACCT AGAACCAGCATAATAAGAAATTTCTTTGGTTCTGTCATTTCAGTATGGACATATTAATATTTTAGCCCACTGAGTTTGTCCAGTTGACAC CATCAGTGCTTCAGTTTTCTCTCTATCCAAAGCAAGGTTTTAACTTTCCTTCATTCTCCAGTAAAACAGACCGAGACAACTTGAACTATA TTTTGAGTATTGCTATATCTTCAACATATAGCTCCAAATGATGGATTGTATACAAAGCATAGTACAGAAGGTTTCAGTAATTGGAAGGTG AACACAGCAATGCTTTACATAATTTGTGTTTTTTAGTAAAAAATATTGGATTCAAAGTAAGCCAATGAGCTTGTATACAAATTTTATATA CAAATTATTGTATAGAACAGTGATATGGAAAATAGGTAAGGGTGATATTAATATCTCTGGGTATAAGGACTACCTTATCGTTTAAATATT TTATTTCCATCTATAGCCTAATATAGAACATTGATTTTCTAGTAGAAATTCTGGGAAGGGCTTTTCTGTCTCTGAAATTGATTCAGTACA GTTGACAGTTCATCACGGTTACCTGGTTAAACACTTTTTTTTTTTTTTTAATTCTCCAGTGATCTAGGAAATTGTTTCATTTTTAACACA GGCTTATTTCTGATGGGGATGGGGGCATAGAATAATATGCCTAATAAGCTAAACGTTCTTAACGTTTCATGTCTTAAACTGTCTTTTTGA ACATTGAGACCACCTCAAGTGCTGTAAAAATAAGAATGTTATATTAGGGGTGTGTGAGACGCCCTAGTCTAAAATCTATCTTTAAATATA TTTCCTTTGTAATTTTCAAAGACTTCAGTAATTGTGTGTTATGGTGGAAATAATACTTTCCATTGGTCCACATTGCTCTGGACCAAACCT GGAGCATTTCTATAATTAGAGCTATCTATGAATCATTAAAAATGGATCTAGAATAATTTTGGGGAGAGGGAGTGTATCATTTAGTTTAGG CTTACCTCAGCAGCACTTCATAGGGTGAGGAGTTGTTTGTTTCTTTAAAGGTATAACTGCATTGTAAAATGACTGGGTTTATTGTAACAG TAATTTATGGGGGCACCCTTTTTGGATTCTCCATTGCCTCAGTTTCCTCAAGGAAAAAGTTACAGAGATTAAGCTAAATTTTGAATTTAG AGAATAACTGCTGTGTAATTTTGGTATAATTACCATAAATTTAGTGTCTTAAAACACAACATACATTATTTCACAATTTCTGTAGGTCAA GAGTGTAGTTAGGTTTTCTGCTCAGGGTCTCACAAGGCTGCAATAAAGGTGTCAGCCAGAGCTGCAGTCTTATCTGAAGCTAGGGGGTCC TCTTTTATGCACATATGGCAAAATCCATTGCCTAGCAACTGAAGAAATCATGGGAACTTCTTCAAGGCCAGCAAGAGAATCTCTGATCTC AGGGAAGGCCTTAAGCGCTTTTTTAAAGGTCTCACCTGATTAGATCAGGCCACCTACCCACCAGGGTGATCTCCCTTTTGATTAACCCAA AGCCAAACTGATGAGGTACCTTCATTACCCCTGCAAAATCCCTTCACCTTTGCCCTGCATTGTAGTCCAATCACAGGGGTGATACGCATC ATATTCAAAGATCCTGTTCACAGTCAAGGGAGGGGGTTATATGGAGTATGTATACCAGGGAATCTTGGGAGCCATCTTAAGAGTTCTTCC TATGACAAGGACTCAACTATTTAGAACTGGAACAATTTACAAGTGATAGCCTTATATAGTTATCATAGCAAGCTTATTTGGGGATCAAGG TTGCCTCTGAGAACCTAATGAAAACTGGACCAGCTTCCCCAAAAAGTGTATATACATGGTAGTTTTTCATACAGTTTTAGGGGATTCATA AGAGTCCATGAATTACAGTCTGTCCCAACCCTTCCCTTTAGATGATGAGTTGTTGAGGTGACTTGCCCAAGGTCACACAGCTACTAAGGG CCAAATAAAGCCCACATCTCAACTCCCATACTGCCCAGGGCTTCTAATTACTATTCTAAAGGTAATCTAAATTCATTTAAATTTGTGAAC CAATGCAAAAAAATGTGAATGTAGCTTTTTGGATATTTTTTTTGTTTACTAAGGAATGGGTAACATTGTTATAGAAGCTTGCCTAAGAGT TTTGAAATTAGTTGACCTTTTTGAGTTTCCAAAATTGAATCTTCCATTGTAGCTATTAAAGTGAACTATAAATAGGCCAACTTTAATTGT TAACTCCTCGGGTTTGGTGGATTATCTACCATTTATATATAAAATTTCAGTTAGAATCCACCATTGGCGTTTTGAAGGCCAAGATAGCTG AGTATCTTATCCTTTTTGTAACTTCTTGATTATTTTACTTATTGGCAAAATTCATTAACTGTCAGCCAATAATTTAATATTATGGGAGGA AAAAATTTTGCCCAGATATCTGAGGCAATACTCCCAAACACTAACAAACTGATGCCTAACAAACTTGACATTTTGAACACTTAAAGTTTT CCCTAAACTTTTTAATAAGCACATTAATAAAGTATGCTTTTAAATATATATGTACAATAATTTTTAAAAGTTGCTGCAAGATGCCTTCAA ATCAATATGCACGTTGGTGGCATTAGTGCAGTCTTCTATTTTTATTTTTTTGAGACACAGTCTCGCTCTGTGGCCCAGGCTGGAGTGTAG TGGCGCAATCTCGGCTCACTGCAACCTCTGCCTCAAGGGTTCAAGCAATTCTGCCTCAGCCTCCTGAGTAGCTGGGATTACAGGAGTACG CTACCACGCCTGGCTAATTTTTGTATTTTTAGTAGAAATGGGGTTTCACCGTATTGGCCAGGCTGGTATTGGAATCCTGACCGCAAATGA TCTGCCCACCTCGGCTTCCCAAAGTGCTGGGATTACAGGCGTGAGCCACTGCGCCCAACCAGCCTTAATTCTTAATAAAGGAAGTTGAAA AATAATGAACATTGGTAAAACTATTCTAGTGTGATCAGAAGCAAATTTGGACTGTAGTGTCAAATTGATAAAAAACTAAGCACACCAATC ATGTATAAGAAAAGTAGATTTAACATTTTTTTCCCTAAACACTTAACCCAGAAGTTAACAATAATCTTGAAAATTCCTTTTAAATCCAGG CCCTTTAGGTGATGGCAGTTTGACTCAGGATGTCCAAGTCCAGTGTATTTTCAATAAAATTGACTTGACAGCTACTGCTCTGGGTGTAAG AGCAGTTGACTGTGAGGAAAAGTAAATGGTTCTACAGATTCTTTATGATCTACCTCCCACCAGAGGACTGCAGTACTCCCTTGTTATTTA TATTTTCTGCCCCAATTTTTGCCTTCTCCACAAATTTTATACCTTTTGTAGCTGCCTACTCCAGATTACTTCACCTTTCCAGACTATCAG TTCTTCCACTTTTATTCTTCATAAAGAAAATTCCAATAACCTGTTTCACTTAGGTTTTTCTATTACTCTTCAAGCATGAATCCTAATTTC CCTGACTATATCTTACCTCTGATCTCCATAACTGATGGATTCCTATCCTAGACTATGTTACTCTAATATTACCCAAGATTTTCTCCAGCC TGTTTTTACTCTTACTTTGAAACAGCTGTTTAAAATGACTCGTAATCTGCTTAAATCTACATGCTTTTTGTGGTTCTCAATCCAGTTACC TACCTTCCAGATAATTCCCTCACTGTCCTGTCCTCTCCATTCCTCTGATGTTTAAGCCCTGTGAGCCACCTTTCCCCCATCCTTTGTGCA TAGTTACCATTTTACTCTTTCTTGTTGCCCAGGCAGGAATGCAGTGGTGCCATCTTGGCTCACTGCAACCTCCACCTCCTAGGTTCAAGC GATTCTCCTGCCTCAGCCTCCTGAGTAGCTGGGACCACAAGCGTGCACCACCACGCCCGGCTAATTTTTGTATTTTTAGTAGAGATGGGG TTTCACCACGTTGGCCAGGCTGGTCTCGAACTCCTGACCTCAGATGATCCACCCTCCTTGGCCTCCCAAAGTGCTGGGATTGCAGGCGTG AGCCACCGCCTGGCCACCATTTTACTCTTTTTAGGTACAGTAATCTAATATCCAAAGTCTTGGACTCAGCTAAAGAGGGTATTTACCTTA AAAAAAAAAAAAAAAAGACTCCATCTTTTGATTCATAATTGTGGTGGGGGCGGGGAATCAAGACAACCTTAGTCACTTTGGTATTACCAT AATTCTTGTCTTTTCAGGGTTGTCCTGTTCAGCTGCATAAAACATCATGTATTCTAGGTATTTCCTACCTTCACTTACATTTTTACTTGC CGATGTGCTGCCTTCATAAATGGGTATATTCCGCCACACATCTAGTAAGCCCCCAATGCAGTACACAATGTGTATCACTGATAAAACTCG CACTTCTGCCATGTCAGTATTATATTCAGTTGAGTGGTCTTTAGCATAGTGGCAGTCCTAGTCATCCTAACCTTTTAGTTAAGGTAAAAT TACATATGTTTATAGAACTCATATAGACAAGCTAGTTTTTAAAATCTTCCTTTTAACCAGTTTAGGATGATCTAGGATAGCTAAGTTACC TACATGGTGACTGTTCGGTCTAATTCAGAAACAGAAGTACTAAAAGAATACTAAAAAGTTTTTACCCATTATCTCTATCCCTGTTTTCTT TTTGCAATTCTCAGCTGCAGGGAGCAAGAAAATACACAGCAGATAGGAAATGTTTGTTTGCATCCTGGCTTTCTCAACCGCACTTTACGT CCTTGAATATTCTAGATATTTACTCCTTCAAGAAGTCAGGAGTATATCCAGGCCTACCTATCATCCTTGCCATCCCCATTAACCCTCATT TTTCAGTATGTGTTTTACATTTATGGTTATTTTTCAGTCTATAGTATCTGTTCACTCATTGCTCTATCACATCTGAGTTTCTCCGTCTTT CTTTCCACTAGATTGTAAGCTCCTTAAGGGCAAGGTCGGCATATAAGCAAAGTTCTGTAAACACCGTGAAGGTACCATGAGTTCTATGGG >1220_1220_1_ACAP2-KPNA4_ACAP2_chr3_195112819_ENST00000326793_KPNA4_chr3_160254628_ENST00000334256_length(amino acids)=541AA_BP=43 MRGGGRMKMTVDFEECLKDSPRFRAALEEVEGDVAELELKLDKTMRRQRNEVVVELRKNKRDEHLLKRRNVPHEDICEDSDIDGDYRVQN TSLEAIVQNASSDNQGIQLSAVQAARKLLSSDRNPPIDDLIKSGILPILVHCLERDDNPSLQFEAAWALTNIASGTSEQTQAVVQSNAVP LFLRLLHSPHQNVCEQAVWALGNIIGDGPQCRDYVISLGVVKPLLSFISPSIPITFLRNVTWVMVNLCRHKDPPPPMETIQEILPALCVL IHHTDVNILVDTVWALSYLTDAGNEQIQMVIDSGIVPHLVPLLSHQEVKVQTAALRAVGNIVTGTDEQTQVVLNCDALSHFPALLTHPKE KINKEAVWFLSNITAGNQQQVQAVIDANLVPMIIHLLDKGDFGTQKEAAWAISNLTISGRKDQVAYLIQQNVIPPFCNLLTVKDAQVVQV VLDGLSNILKMAEDEAETIGNLIEECGGLEKIEQLQNHENEDIYKLAYEIIDQFFSSDDIDEDPSLVPEAIQGGTFGFNSSANVPTEGFQ -------------------------------------------------------------- |
Top |
Fusion Gene PPI Analysis for ACAP2-KPNA4 |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for ACAP2-KPNA4 |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for ACAP2-KPNA4 |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Copyright 2021-Present -The University of Texas Health Science Center at Houston (UTHealth)
Web File Viewing | Emergency Information |Campus Carry|Site Policies